Journal Information
Vol. 28. Issue 7.
Pages 337-340 (October 1992)
Share
Share
Download PDF
More article options
Vol. 28. Issue 7.
Pages 337-340 (October 1992)
Full text access
Indicaciones quirúrgicas del carcinoma broncopulmonar de células pequeñas
Surgical indications in small cell lung cancer
Visits
3152
E. Canalís, J. Albort
Servicio de Cirugía Torácica, Hospital Clínico y Provincial de Barcelona
J.J. Grau*
* Servicio de Coordinación Oncológica. Hospital Clínico y Provincial de Barcelona
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics

Los autores proponen un tratamiento multidisciplinario del carcinoma broncopulmonar de células pequeñas, incluyendo la cirugía, en estadios poco avanzados.

Esta propuesta nace por un lado de la observación anecdótica de los buenos resultados en resecciones pulmonares en esta estirpe anatomopatológica, y por otro de que la respuesta de este tumor a la quimioterapia es buena, si bien la recidiva local es frecuente.

Tras revisar los resultados esperanzadores de diversos autores con este enfoque multidisciplinario, se concluye que el diagnóstico de carcinoma microcítico de pulmón puede no equivaler a caso perdido y que tras un estadiaje exacto debe contemplarse la posibilidad de cirugía asociada a quimioterapia en estadios I a IIIa.

The authors propose a multidisciplinary treatment for small cell lung cancer which includes surgery in nonadvanced stages. This proposal is based on one hand, on anecdotal observations with good results after pnlmonary resection, and on the other hand, on the favourable response to chemotherapy, eventhough local relapse is frequent. After reviewing the encouraging results obtained by other authors with a multidisciplinary approach, we conclude that the diagnosis of microcytic pulmonary carcinoma does not represent necessarily a dead loss. The tumor stage has to be determined accurately, and surgery associated with chemotherapy should be envisaged in stages Ia and IIIa.

Full text is only aviable in PDF
Bibliografía
[1.]
D. Anthoine, X. Feintrenie.
El cáncer bronquial microcelular..
Press Méd (ed esp), 4 (1989), pp. 230-235
[2.]
M.D. Abeloff, J. Eggleston, G. Mendelsohn.
Cambios en las características morfológicas y bioquímicas del carcinoma de células pequeñas de pulmón..
Am J Med (ed esp), 66 (1979), pp. 351-364
[3.]
R. Yesner.
A unified concept of lung cancer histopathology.
Am Soc Clin One Proc, 1 (1977), pp. 271-275
[4.]
D.C. Ihde.
Current status of therapy for small cell carcinoma of the lung.
Cancer, 54 (1984), pp. 2722-2728
[5.]
M.J. Straus.
Lung Cancer.
Grune Straton, (1983), pp. 21-35
[6.]
Recomendaciones SEPAR.
Normativa sobre nomenclatura y clasificación del carcinoma broncogénico.
Sociedad Española de Patología Respiratoria, (1986), pp. 9-22
[7.]
T.W. Shields.
Surgical resection in the management of small cell carcinoma of the lung.
J Thorac Cardiovasc Surg, 83 (1982), pp. 12-19
[8.]
A. Ordoñez Gallego, C. García Girón, J. Feliu Batlle.
Estado actual en el tratamiento del carcinoma broncopulmonar de células pequeñas.
Arch Bronconeumol, 24 (1988), pp. 15-20
[9.]
M. Zelen.
Key note address on biostatistics and data retrieval.
Cancer Chemother Rep, 4 (1973), pp. 31-42
[10.]
J. Estapé, A. Millá, A. Agustí, et al.
VP16 plus cyclophosphamide in the treatment of advanced lung cancer.
Cancer, 51 (1983), pp. 385-389
[11.]
P. Santabárbara, J. Estapé, A. Agustí-Vidal, et al.
VP16.213 y ciclofosfamida en el carcinoma de células pequeñas de pulmón.
Neoplasia, 3 (1986), pp. 73-79
[12.]
P. Santabárbara, J. Estapé, A. Agustí, et al.
Asociación de VP 16.213, ciclofosfamida y adriamicina, en el carcinoma de células pequeñas de pulmón.
Neoplasia, 5 (1988), pp. 82-86
[13.]
C. Solá, J.J. Grau, J. Estapé, et al.
Cisplatino, adriamicina, etopósido y ciclofosfamida (CARE) en el carcinoma pulmonar de células pequeñas.
Neoplasia, 8 (1991), pp. 83-86
[14.]
J. Abrans, L.A. Doyle, J. Aisner.
Staging prognostic factors, and special considerations in small cell lung cancer.
Sem Oncol, 15 (1988), pp. 261-277
[15.]
E. Frei.
Curative cancer chemotherapy.
Cancer Res, 45 (1985), pp. 6523-6537
[16.]
M.C. Perry, W.L. Eaton, K.L. Prospert, et al.
Chemotherapy with and without radiation therapy in limited small-cell carcinoma of the lung.
N Eng J Med, 316 (1987), pp. 912-918
[17.]
R.S. Aroney, J. Aisner, M.N. Nesley, et al.
Value of prophylactic craneal irradiation given at complete remission in small cell lung carcinoma.
Cancer Treat Sep, 67 (1983), pp. 675-682
[18.]
V. Levison.
What is the best treatment for early operable small cell carcinoma of the bronchus?.
Thorax, 35 (1980), pp. 721-724
[19.]
B.L. Graham, L. Balducci, T. Khansur, M.L. Dalton, B. Lambuth.
Surgery in small cell lung cancer.
Ann Thorac Surg, 45 (1988), pp. 687-692
[20.]
Denck H, Karnicka-Mlodkowska H, Vogt-Moykopf J et al. Surgery for cure followed by chemo and radio-therapy for small cell lung carcinoma. 2nd Annual Meeting of the European Association for Cardio-Thoracic Surgery. Bordeaux, France, 1988.
[21.]
N. Hara, M. Ohta, Y. Ichinose, A. Motohiro, et al.
Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer.
J Surg Oncol, 47 (1991), pp. 53-61
[22.]
F.A. Shepherd, R.J. Ginsberg, R. Feld, W.K. Evans, E. Johansen.
Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group Experience..
J Thorac Cardiovasc Surg, 101 (1991), pp. 385-393
[23.]
F.A. Shepherd, R.J. Ginsberg, G.A. Patterson, R. Feld, P.E. Goss, F.G. Pearson.
Is there ever a role for salvage operations in limited small-cell lung cancer?.
J Thorac Cardiovasc Surg, 101 (1991), pp. 196-200
Copyright © 1992. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?